ATE373662T1 - Tyrosinkinase-hemmer - Google Patents
Tyrosinkinase-hemmerInfo
- Publication number
- ATE373662T1 ATE373662T1 AT03719886T AT03719886T ATE373662T1 AT E373662 T1 ATE373662 T1 AT E373662T1 AT 03719886 T AT03719886 T AT 03719886T AT 03719886 T AT03719886 T AT 03719886T AT E373662 T1 ATE373662 T1 AT E373662T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- tyrosine kinase
- kinase inhibitors
- present
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37223202P | 2002-04-12 | 2002-04-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE373662T1 true ATE373662T1 (de) | 2007-10-15 |
Family
ID=29250816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03719886T ATE373662T1 (de) | 2002-04-12 | 2003-04-08 | Tyrosinkinase-hemmer |
Country Status (9)
Country | Link |
---|---|
US (1) | US7371754B2 (de) |
EP (1) | EP1496907B1 (de) |
JP (1) | JP4475389B2 (de) |
AT (1) | ATE373662T1 (de) |
AU (1) | AU2003223689B2 (de) |
CA (1) | CA2480758A1 (de) |
DE (1) | DE60316423T2 (de) |
ES (1) | ES2292956T3 (de) |
WO (1) | WO2003086315A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003231747B2 (en) | 2002-04-12 | 2008-09-18 | Merck Sharp & Dohme Corp. | Tyrosine kinase inhibitors |
US20050239815A1 (en) * | 2002-04-12 | 2005-10-27 | Kim Annette J | Tyrosine kinase inhibitors |
US8428136B2 (en) | 2006-03-09 | 2013-04-23 | Nec Corporation | Dynamic image encoding method and device and program using the same |
US8530475B2 (en) | 2006-05-18 | 2013-09-10 | Janssen Pharmaceutica Nv | Bridged aryl piperazines derivatives useful for the treatment of CNS, GI-urinary and reproductive disorders |
US8642067B2 (en) | 2007-04-02 | 2014-02-04 | Allergen, Inc. | Methods and compositions for intraocular administration to treat ocular conditions |
CN117257805B (zh) * | 2023-11-10 | 2024-03-12 | 中山大学附属第八医院(深圳福田) | 核苷类逆转录酶抑制剂在制备抗血管钙化药物中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4332810A (en) | 1981-01-26 | 1982-06-01 | Merck & Co., Inc. | N-(Substituted)-2,5-ethano-8-hydroxy (or methoxy)-1,2,3,4,5,6-hexahydro-3 (or 4)-benzazocine centrally-acting analgesics |
US6921765B2 (en) | 2000-09-20 | 2005-07-26 | Aprea Ab | 1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors |
GB0110797D0 (en) * | 2001-05-02 | 2001-06-27 | Celltech R&D Ltd | Chemical compounds |
AU2003231747B2 (en) | 2002-04-12 | 2008-09-18 | Merck Sharp & Dohme Corp. | Tyrosine kinase inhibitors |
US20050239815A1 (en) | 2002-04-12 | 2005-10-27 | Kim Annette J | Tyrosine kinase inhibitors |
-
2003
- 2003-04-08 WO PCT/US2003/012457 patent/WO2003086315A2/en active IP Right Grant
- 2003-04-08 AT AT03719886T patent/ATE373662T1/de not_active IP Right Cessation
- 2003-04-08 ES ES03719886T patent/ES2292956T3/es not_active Expired - Lifetime
- 2003-04-08 CA CA002480758A patent/CA2480758A1/en not_active Abandoned
- 2003-04-08 EP EP03719886A patent/EP1496907B1/de not_active Expired - Lifetime
- 2003-04-08 JP JP2003583340A patent/JP4475389B2/ja not_active Expired - Lifetime
- 2003-04-08 AU AU2003223689A patent/AU2003223689B2/en not_active Ceased
- 2003-04-08 US US10/510,610 patent/US7371754B2/en not_active Expired - Fee Related
- 2003-04-08 DE DE60316423T patent/DE60316423T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2292956T3 (es) | 2008-03-16 |
EP1496907A4 (de) | 2006-05-10 |
AU2003223689B2 (en) | 2009-08-20 |
EP1496907A2 (de) | 2005-01-19 |
CA2480758A1 (en) | 2003-10-23 |
DE60316423T2 (de) | 2008-06-12 |
DE60316423D1 (de) | 2007-10-31 |
JP4475389B2 (ja) | 2010-06-09 |
JP2005528387A (ja) | 2005-09-22 |
US7371754B2 (en) | 2008-05-13 |
AU2003223689A1 (en) | 2003-10-27 |
WO2003086315A2 (en) | 2003-10-23 |
EP1496907B1 (de) | 2007-09-19 |
WO2003086315A3 (en) | 2004-01-08 |
US20050227988A1 (en) | 2005-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE482938T1 (de) | Tyrosinkinaseinhibitoren | |
WO2004014300A3 (en) | Tyrosine kinase inhibitors | |
WO2003035615A3 (en) | Tyrosine kinase inhibitors | |
DK1362047T3 (da) | Indazolylsubstituerede pyrrolinforbindelser som kinaseinhibitorer | |
WO2004031401A3 (en) | Novel tyrosine kinases inhibitors | |
WO2001064681A3 (en) | 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors | |
WO2006047479A3 (en) | C-fms kinase inhibitors | |
MXPA02005844A (es) | Inhibidores de cinasas de proteina. | |
WO2004096795A3 (en) | C-fms kinase inhibitors | |
ATE554087T1 (de) | Neue kinaseinhibitoren | |
ID27535A (id) | Turunan pirasola sebagai inhibitor p-38 map kinase | |
WO2003035616A3 (en) | Tyrosine kinase inhibitors | |
SG132683A1 (en) | Imidazopyrazine tyrosine kinase inhibitors | |
BRPI0412876A (pt) | derivados de quinolinona como inibidores de c-fms quinase | |
CA2400447A1 (en) | Kinase inhibitors | |
MY139689A (en) | Imidazotriazines as protein kinase inhibitors | |
WO2003035619A8 (en) | Tyrosine kinase inhibitors | |
WO2006047503A3 (en) | Inhibitors of c-fms kinase | |
ATE419253T1 (de) | Inhibitoren von thienopyridin- und furopyridinkinase | |
WO2003035614A3 (en) | Tyrosine kinase inhibitors | |
MXPA05013076A (es) | Compuestos de isoindolina-1-ona como inhibidores de cinasa. | |
BRPI0407841A (pt) | inibidores heterocìclicos de quinase | |
TW200628153A (en) | Novel compounds | |
ATE373662T1 (de) | Tyrosinkinase-hemmer | |
ATE396727T1 (de) | Tyrosinkinase-hemmer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |